Literature DB >> 21656277

Newly developed liquid-based cytology. TACAS™: cytological appearance and HPV testing using liquid-based sample.

Kaneyuki Kubushiro1, Hideki Taoka, Nobuyuki Sakurai, Yasuhiro Yamamoto, Akiko Kurasaki, Yasuyuki Asakawa, Minoru Iwahara, Kei Takahashi.   

Abstract

Cell profiles determined by the thin-layer advanced cytology assay system (TACAS™), a liquid-based cytology technique newly developed in Japan, were analyzed in this study. Hybrid capture 2 (HC-2) was also performed using the liquid-based samples prepared by TACAS to ascertain its ability to detect human papillomavirus (HPV). Cell collection samples from uterine cervix were obtained from 359 patients and examined cytologically. A HC-2 assay for HPV was carried out in the cell specimens. All specimens were found to show background factors such as leukocytes. After excluding the 5 unsatisfactory cases from the total 354 cases, 82 cases (23.2%) were positive and 272 cases (76.8%) were negative for HPV. Cell specimens from 30 HPV-positive cases and 166 HPV-negative cases were subjected to 4 weeks of preservation at room temperature. Then, when subsequently re-assayed, 28 cases (93.3%) in the former group were found to be HPV positive and 164 cases (98.8%) in the latter group were found to be HPV negative. These results supported the excellent reproducibility of TACAS for HPV testing. A reasonable inference from the foregoing analysis is that TACAS may be distinguished from other liquid-based cytological approaches, such as ThinPrep and SurePath, in that it can retain the cell backgrounds. Furthermore, this study raises the possibility that cell specimens prepared using TACAS could be preserved for at least 4 weeks prior to carrying out a HC-2 assay for HPV.

Entities:  

Mesh:

Year:  2011        PMID: 21656277     DOI: 10.1007/s13577-011-0020-5

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  29 in total

1.  Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood.

Authors:  Brenda J Sweeney; Zafarul Haq; James F Happel; Barbara Weinstein; Douglas Schneider
Journal:  Cancer       Date:  2006-02-25       Impact factor: 6.860

2.  Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer.

Authors:  B Kirschner; K Simonsen; J Junge
Journal:  Cytopathology       Date:  2006-08       Impact factor: 2.073

3.  Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology.

Authors:  A Ferenczy; J Robitaille; E Franco; J Arseneau; R M Richart; T C Wright
Journal:  Acta Cytol       Date:  1996 Nov-Dec       Impact factor: 2.319

4.  Effectiveness of thin-layer preparations vs. conventional Pap smears in a blinded, split-sample study. Extended cytologic evaluation.

Authors:  J J Hessling; D S Raso; B Schiffer; J Callicott; M Husain; D Taylor
Journal:  J Reprod Med       Date:  2001-10       Impact factor: 0.142

5.  Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep Pap Test with the conventional Pap Test, including follow-up of HSIL cases.

Authors:  J H Obwegeser; S Brack
Journal:  Acta Cytol       Date:  2001 Sep-Oct       Impact factor: 2.319

6.  Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy.

Authors:  C Bergeron; J Bishop; A Lemarie; F Cas; J Ayivi; B Huynh; R Barrasso
Journal:  Acta Cytol       Date:  2001 Jul-Aug       Impact factor: 2.319

7.  Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples.

Authors:  Jae Kwan Lee; Mi Kyung Kim; Seung Hun Song; Jin Hwa Hong; Kyung Jin Min; Jae Hoon Kim; Eun-Seop Song; Jungpil Lee; Jong-Min Lee; Soo-Young Hur
Journal:  Int J Gynecol Cancer       Date:  2009-02       Impact factor: 3.437

8.  Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.

Authors:  Björn Strander; Agneta Andersson-Ellström; Ian Milsom; Thomas Rådberg; Walter Ryd
Journal:  Cancer       Date:  2007-10-25       Impact factor: 6.860

9.  High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.

Authors:  A Hardie; C Moore; J Patnick; K Cuschieri; C Graham; C Beadling; K Ellis; V Frew; H A Cubie
Journal:  Cytopathology       Date:  2009-08       Impact factor: 2.073

10.  Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Journal:  BMJ       Date:  2009-07-28
View more
  2 in total

1.  The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.

Authors:  Yoshihito Yokoyama; Masayuki Futagami; Jun Watanabe; Atsushi Sakuraba; Kazuma Nagasawa; Hidetoshi Maruyama; Shigemi Sato
Journal:  Hum Cell       Date:  2016-01-06       Impact factor: 4.174

2.  Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.

Authors:  Yoko Shirai; Kenichiro Miura; Takashi Yokoyama; Shigeru Horita; Hideki Nakayama; Hiroshi Seino; Taro Ando; Atsutoshi Shiratori; Tomoo Yabuuchi; Naoto Kaneko; Sho Ishiwa; Kiyonobu Ishizuka; Masanori Hara; Motoshi Hattori
Journal:  Kidney360       Date:  2020-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.